Soraya Bekkali, Alexion SVP Europe, Canada and International region, discusses the realities patients with generalised Myasthenia Gravis face across Europe, and how modernised, evidence-based care pathways and equitable access are key to closing care gaps and improving patient outcomes in rare neuromuscular diseases. EV: Alexion is at the forefront of therapeutic innovation in rare neuromuscular […]